GRÜNENTHAL LICENSES EXCLUSIVE SOUTH KOREAN RIGHTS TO QUTENZA® TO BCWORLD PHARM

Contributed by: News Aktuell

Issued by news aktuell/OTS on behalf of Grünenthal Group

Logo

Tags

Medical profession

Medicine

More Like This

GRÜNENTHAL LICENSES EXCLUSIVE AUSTRALIAN RIGHTS TO QUTENZA® TO CLINECT

APOTEX LICENSES EXCLUSIVE CANADIAN RIGHTS TO QUTENZA® FROM GRÜNENTHAL

PR Newswire associated0

Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics

GRÜNENTHAL TAKES FULL OWNERSHIP OF GRÜNENTHAL MEDS, THE JOINT VENTURE ESTABLISHED WITH KYOWA KIRIN FOR ITS ESTABLISHED MEDICINES BRANDS

QPS Neuropharmacology facility in Grambach, Austria. (Graphic: Business Wire)

QPS Holdings, LLC divests its Neuropharmacology Business Unit

GRÜNENTHAL'S PROPRIETARY NAV 1.8 INHIBITOR ENTERS CLINICAL DEVELOPMENT

PR Newswire associated0

Tetra Pharm Technologies introduces pain relieving drug in the United Kingdom

GRÜNENTHAL LICENSES EXCLUSIVE CANADIAN RIGHTS TO TESTOSTERONE REPLACEMENT THERAPY NEBIDO® TO APOTEX